Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
COR
TEVA
Add up to 3 more stocks
COR
Cencora, Inc.
+0.19%
$321.57+0.62Delayed quote: Sep 11, 2026, 4:00 PM EDT
Market Cap
$62.57B
52W Range
$244.82 - $377.54
TEVA
Teva Pharmaceutical Industries Limited
+2.05%
$37.09+0.75Delayed quote: Sep 11, 2026, 4:00 PM EDT
Market Cap
$43.20B
52W Range
$18.21 - $38.37
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 23.89 | 61.82 |
| Forward P/E | 17.99 | 18.72 |
| P/B Ratio | 20.51 | 5.57 |
| P/S Ratio | 0.19 | 2.49 |
| P/FCF Ratio | 15.41 | 32.04 |
| EV/EBITDA | 13.27 | 18.98 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 3.7% | 52.5% |
| Operating Margin | 1.3% | 11.4% |
| Net Margin | 0.8% | 4.1% |
| ROE | 86.0% | 9.1% |
| ROA | 3.1% | 1.8% |
| ROIC | 12.8% | 6.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 0.93 | 0.88 |
| Quick Ratio | 0.58 | 0.67 |
| Debt/Equity | 3.84 | 2.18 |
| Interest Coverage | 8.69 | 2.35 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 0.8% | N/A |
| Payout Ratio | 17.8% | N/A |
| Yrs of Dividend Growth | 20 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.